DEA again extends flexibility for virtual buprenorphine induction

As the Drug Enforcement Administration (DEA) adds another year to flexibilities for prescribing of buprenorphine through telemedicine, evidence from the addiction treatment community continues to suggest the benefits of making this COVID‐era change permanent.

Authors

Publication Details

Journal
Alcoholism & Drug Abuse Weekly
Published
2024-12-06
DOI
https://doi.org/10.1002/adaw.34341
Primary Topic
Opioid Use Disorder Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

DEA again extends flexibility for virtual buprenorphine induction

Gary A. Enos
Alcoholism & Drug Abuse Weekly
Opioid Use Disorder Treatment
article

DEA again extends flexibility for virtual buprenorphine induction

Gary A. Enos
article en

Abstract

As the Drug Enforcement Administration (DEA) adds another year to flexibilities for prescribing of buprenorphine through telemedicine, evidence from the addiction treatment community continues to suggest the benefits of making this COVID‐era change permanent.

Alcoholism & Drug Abuse WeeklyVol. 36(46)
Good health and well-being
Openalex Percentile: Top 66%
Opioid Use Disorder Treatment
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

DEA again extends flexibility for virtual buprenorphine induction — Gary A. Enos · Alcoholism & Drug Abuse Weekly (2024) | TGRS Research Map | TGRS